Immunohistochemical markers augment evaluation of vaccine efficacy and disease severity in bacillus Calmette–Guerin (BCG) vaccinated cattle challenged with Mycobacterium bovis
- 15 June 2006
- journal article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 111 (3-4) , 219-229
- https://doi.org/10.1016/j.vetimm.2006.01.016
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The success and failure of BCG — implications for a novel tuberculosis vaccineNature Reviews Microbiology, 2005
- Bioactivation of Latent Transforming Growth Factor beta1 by Mycobacterium tuberculosis in Human Mononuclear PhagocytesScandinavian Journal of Immunology, 2005
- Differential Effects of Control and Antigen-Specific T Cells on Intracellular Mycobacterial GrowthInfection and Immunity, 2003
- Use of the bovine model of tuberculosis for the development of improved vaccines and diagnosticsTuberculosis, 2003
- Gamma Interferon-Producing CD4+T Lymphocytes in the Lung Correlate with Resistance to Infection withMycobacterium tuberculosisInfection and Immunity, 2001
- Restraining mycobacteria: Role of granulomas in mycobacterial infectionsImmunology & Cell Biology, 2000
- The Role of TGFβ in the Pathogenesis of Human TuberculosisClinical Immunology and Immunopathology, 1998
- Differential Effects of Cytolytic T Cell Subsets on Intracellular InfectionScience, 1997
- Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literatureJAMA, 1994
- The BCG Story: Lessons from the Past and Implications for the FutureClinical Infectious Diseases, 1989